Latest Listings And Ipos News

Aguia Resources has scrapped its planned convertible note issue, converting $750,000 in subscriptions into a secured loan with a potential share conversion feature, pending shareholder approval.

Mindax Limited has raised $1.6 million through a discounted share placement to fund development and exploration activities at its Mt Forrest Iron Project and gold assets.

ASX Compliance has formally questioned Rewardle Holdings Limited over delayed disclosures, financial inconsistencies, and governance concerns tied to its investments in Pepper Leaf, Beanhunter, and CloudHolter.

Biome Australia Limited has confirmed its record FY25 sales revenue of approximately $18.4 million, marking a 41% increase year-on-year, while affirming full compliance with ASX continuous disclosure rules.

Mithril Silver and Gold Limited has announced a C$10 million brokered private placement to fund expanded exploration at its Copalquin district project in Mexico. The raise includes an option for agents to increase the placement by 15%, underscoring strong investor interest.

Blackstone Minerals has launched a $2 million Share Purchase Plan at a 9% discount, running alongside a $22.6 million placement to institutional investors. Eligible shareholders in Australia and New Zealand can buy shares up to $30,000, supporting the company’s Mankayan Copper-Gold Project expansion.

Pantera Lithium Limited has agreed to sell its Smackover lithium brine project in Arkansas to Energy Exploration Technologies for A$40 million, combining cash and stock consideration while retaining equity exposure to the lithium sector.

Hiremii Limited has announced the acquisition of Prince Migration & Education, marking a strategic expansion into Australia's East Coast and diversifying its talent acquisition services with migration expertise.

Almonty Industries has requested a voluntary suspension of its ASX-listed securities pending the release of an updated technical report on its Sangdong Project in South Korea. The suspension will last until trading resumes on 11 July or the announcement is made.

Island Pharmaceuticals has accelerated its acquisition of the Galidesivir antiviral program from BioCryst Pharmaceuticals, adding a clinically advanced asset with significant US government backing and a promising regulatory pathway.

Orthocell Limited has reported a record FY2025 revenue of A$9.19 million, driven by strong sales of its nerve repair product Remplir™ in Australia and a promising US market launch following FDA clearance.

Resolution Minerals has secured final US Forest Service permits to begin drilling at its Horse Heaven Project, targeting gold, antimony, and tungsten. The company also advances its acquisition, setting the stage for exploration later this year.